Patents by Inventor Anne Goldby

Anne Goldby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES
    Publication number: 20230073334
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Application
    Filed: October 10, 2022
    Publication date: March 9, 2023
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
    Patent number: 11512066
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: November 29, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES
    Publication number: 20200190059
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Application
    Filed: December 9, 2019
    Publication date: June 18, 2020
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions
    Patent number: 10562882
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: February 18, 2020
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Anne Goldby, Kerry Jenkins, Martin Teall
  • Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
    Patent number: 10544126
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: January 28, 2020
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES
    Publication number: 20190084962
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Application
    Filed: November 19, 2018
    Publication date: March 21, 2019
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • INDANE DERIVATIVES AS MGLUR7 MODULATORS
    Publication number: 20190031599
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4a and R4b are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: January 24, 2017
    Publication date: January 31, 2019
    Inventors: Anne Goldby, Gemma Liwicki, Stephen Mack, Martin Teall, Katy White
  • Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
    Patent number: 10167273
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: January 1, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • Piperidine and azepine derivatives as prokineticin receptor modulators
    Patent number: 10160745
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions N containing them and their use in therapy.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: December 25, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • 3-substituted 2-amino-indole derivatives
    Patent number: 10059713
    Abstract: The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: August 28, 2018
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Gregory Barker, Richard Davenport, Robert Downham, William Farnaby, Anne Goldby, Duncan Hannah, David Harrison, Henriette Willems
  • PIPERIDINE AND AZEPINE DERIVATIVES AS PROKINETICIN RECEPTOR MODULATORS
    Publication number: 20180009780
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions N containing them and their use in therapy.
    Type: Application
    Filed: September 12, 2017
    Publication date: January 11, 2018
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • Piperidine and azepine derivatives as prokineticin receptor modulators
    Patent number: 9790201
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: October 17, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • Piperidine Derivatives for Use in the Treatment or Prevention of Psychiatric and Neurological Conditions
    Publication number: 20170166553
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: November 26, 2014
    Publication date: June 15, 2017
    Inventors: Anne Goldby, Kerry Jenkins, Martin Teall
  • 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES
    Publication number: 20170158700
    Abstract: The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
    Type: Application
    Filed: June 24, 2015
    Publication date: June 8, 2017
    Inventors: Gregory BARKER, Richard DAVENPORT, Robert DOWNHAM, William FARNABY, Anne GOLDBY, Duncan HANNAH, David HARRISON, Henriette WILLEMS
  • SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES
    Publication number: 20160376256
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
    Type: Application
    Filed: September 12, 2016
    Publication date: December 29, 2016
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
    Patent number: 9475795
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof: (I) in which m, n, W, X, Y, Z, R1, R2, R3 and R4 are as defined in the specification, for use in the treatment or prevention of a diseases o conition mediated by a prokineticin, such as psychiatric and neurological conditions.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: October 25, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • PIPERIDINE AND AZEPINE DERIVATIVES AS PROKINETICIN RECEPTOR MODULATORS
    Publication number: 20160185752
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 7, 2014
    Publication date: June 30, 2016
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Sarah BOUSBA, Anne GOLDBY, Kerry JENKINS, Natasha KINSELLA, Martin TEALL
  • SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES
    Publication number: 20150111922
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof: (I) in which m, n, W, X, Y, Z, R1, R2, R3 and R4 are as defined in the specification, for use in the treatment or prevention of a diseases o conition mediated by a prokineticin, such as psychiatric and neurological conditions.
    Type: Application
    Filed: May 29, 2013
    Publication date: April 23, 2015
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Colm Carroll, Anne Goldby, Martin Teall
  • THERAPEUTIC COMPOUNDS
    Publication number: 20130324576
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which m, n, W, X, Y, Z, R, R1, R2, R3 and R4 are as defined in the specification, for use in therapy.
    Type: Application
    Filed: May 29, 2013
    Publication date: December 5, 2013
    Inventors: Colm Carroll, Anne Goldby, Martin Teall